Skip to main content

E Fund Management Co., Ltd.

Position in NBIX — Neurocrine Biosciences Inc

CIK 1842296 GUANGZHOU, F4

Position in NBIX

as of Mar 31, 2026 · filed Apr 13, 2026
Position Value
$591,380
-$494,832 QoQ
Shares Held
4,489
-48.1% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2022
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

E Fund Management Co., Ltd. holds $3,498,956 across 9 Drug Manufacturers - Specialty & Generic names. NBIX ranks #3 (16.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 NBIX
Neurocrine Biosciences Inc
This page
4,489 $591,380

All Filings in NBIX

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $591,380 4,489
2025-06-30 $1,086,212 8,642
2025-03-31 $1,024,377 9,262
2024-12-31 $1,015,696 7,441
2024-09-30 $1,023,960 8,887
2024-06-30 $1,007,606 7,319
2024-03-31 $429,344 3,113
2023-12-31 $539,688 4,096
2023-09-30 $471 4,185
2023-06-30 $451 4,783
2023-03-31 $408 4,031
2022-12-31 $431 3,606
2022-09-30 $475,077 4,473
2022-06-30 $452,599 4,643
2022-03-31 $281,718 3,005